- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 15:46 | Merck KGaA to buy Bio-Techne for $11.3bn in life science footprint expansion | ||
| 11:46 | MSD's Keytruda-Padcev combo secures EC approval for MIBC | ||
| 10:46 | RQ Bio secures $115m to develop influenza antibody programme | ||
| 08:46 | BIO 2026: How NIH cuts have threatened US competitiveness against China | ||
| Mi | Novartis targets undruggable cancers with $1.9bn Antares Therapeutics deal | ||
| Mi | OURA and Lilly join forces to harmonise drug-wearable obesity care | ||
| Mi | Boehringer and Combotope partner for cancer antibodies | ||
| Mi | Haisco and Nuvectis sign licensing deal for two drugs | ||
| Di | BIO 2026: NVIDIA announces the BioNeMo toolkit for AI agents | ||
| Di | FDA changes rare disease tune again as it clears path for Regenxbio's gene therapy | ||
| Di | Genprex's Reqorsa combo secures Canadian patent for lung cancer | ||
| Di | BIO 2026: Drug manufacturers band together to tackle employment challenges | ||
| Di | Lilly and BioArctic sign deal to develop neurodegenerative therapy | ||
| Mo | AbbVie deepens immunology legacy in $10.9bn Apogee buyout | ||
| Mo | HLTH Europe 2026: enriching the patient journey with health technologies | ||
| Mo | Moderna's mRNA flu vaccine passes FDA AdCom, review underway | ||
| Mo | Moderna's mRNA flu vaccine set for FDA review after positive AdCom | ||
| Mo | Sun Pharma to acquire Innovcare Lifesciences for $28.7m | ||
| Mo | Japan approves Sanofi's Sarclisa combo for MM treatment | ||
| Fr | Biopharma industry confidence at highest in years despite geopolitical headwinds | ||
| Fr | Voro and Alloy partner on tumour-selective TCE therapeutics | ||
| Fr | Biogen to acquire RayThera for up to $1bn | ||
| 18.06. | UniQure to seek approval of Huntington's gene therapy after FDA U-turn | ||
| 18.06. | Jazz and AbCellera sign deal for T-cell engagers in solid tumours | ||
| 18.06. | LG AI Research and D&D Pharmatech sign agreement for oral peptide drugs |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.